Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2020, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Asenapine Sublingual Tablets, 5 mg and 10 mg.".
Press Release Dec 11 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Alembic Pharmaceuticals Limited on 6ix
Earlier from Alembic Pharmaceuticals
- Press Release Dec 03 2020
- Press Release Dec 02 2020
- Press Release Nov 25 2020
- Press Release Nov 09 2020
- Press Release Oct 26 2020
Later from Alembic Pharmaceuticals
- Press Release Jan 22 2021
- Press Release Feb 09 2021
- Press Release Feb 12 2021
- Press Release Mar 04 2021
- Press Release Apr 01 2021
Follow Alembic Pharmaceuticals into a list and get an email when it puts out news.
Follow Alembic Pharmaceuticals